Node and Atrial Fibrillation Ablation for Persistent Atrial Fibrillation

Launched by EASTBOURNE GENERAL HOSPITAL · Jan 26, 2010

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with symptomatic drug refractory atrial fibrillation.
• • Patients who have had pacemaker implantation and AV node ablation with ongoing symptoms.
• • Patients will already be refractory to at least 2 rate or rhythm control drugs.
• • Patients must be over 18 years old.
• • Patients give informed consent form prior to participating in this study.
• Exclusion Criteria:
• • Patient is suffering with unstable angina in last 1 week.
• • Patient has had a myocardial infarction within last 2 months.
• • Patient is expecting or has had major cardiac surgery within last 2 months.
• • Patient is participating in a conflicting study.
• • Patient is unable to perform exercise testing.
• • Patient is mentally incapacitated and cannot consent or comply with follow-up.
• • Patient has NYHA class III/ IV heart failure.
• • Patient has LVEF \<35% not secondary to tachycardia.
• • Pregnancy.
• • Patient suffers with other cardiac rhythm disorders.
• • Recent coronary artery intervention or other factors suggesting clinical instability (ECG, clinical or laboratory findings).